Donate
Australian & New Zealand Childrens Haematology/Oncology Group

ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
A phase II study of trametinib in paediatric, adolescent and young adult patients with neurofibromatosis type 1 associated plexiform neurofibromas or progressive optic pathway gliomas
Protocol ID
TiNT
Disease (Sub Disease)
Solid tumours (Other Solid Tumour)
Diagnosis Stage
Relapsed/ refractory
Location
NSW, QLD, VIC, WA, NZ, TAS
Sponsor
Australian and New Zealand Children's Haematology Oncology Group
Trial Status
Open
Sites
The Children's Hospital at Westmead
Perth Children's Hospital
Queensland Children's Hospital
Sydney Children's Hospital
Royal Children's Hospital
Royal Hobart Hospital
Christchurch Hospital
Starship Hospital
Study Type
Treatment
Phase
Phase 2
Age Eligibility
3 Months to 25 Years
ANZCTR
ACTRN12620001229965
Back to Registry
Study Title A phase II study of trametinib in paediatric adolescent and young adult patients with neurofibromatosis type 1 associated plexiform neurofibromas or progressive optic pathway gliomas
Protocol ID TiNT
Disease (Sub Disease) Solid tumours (Other Solid Tumour)
Diagnosis Stage Relapsed/ refractory
Location NSW / QLD / VIC / WA / NZ / TAS
Sponsor Australian and New Zealand Children's Haematology Oncology Group
Links https://anzctr.org.au/Trial/Registration/TrialReview.aspx?id=379244&isReview=true
Trial Status Open
Trial Open Date 01/03/2021
Sites The Children's Hospital at Westmead / Perth Children's Hospital / Queensland Children's Hospital / Sydney Children's Hospital / Royal Children's Hospital / Royal Hobart Hospital/ Christchurch Hospital / Starship Hospital
Study Type Treatment
Phase Phase 2
Age Eligibility 3 Months to 25 Years
ANZCTR ACTRN12620001229965